NCT00823524
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- University of Ulsan, Asan Medical Center Seoul, South Korea
Clinical trial condition
Leukemia, Prolymphocytic
Explore clinical trials studying Leukemia, Prolymphocytic. Study availability and eligibility vary by location and protocol.
124 public trials
7 recruiting studies
Leukemia, Prolymphocytic trial results
NCT00002980
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Beckman Research Institute, City of Hope Duarte, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- Los Angeles County-University of Southern California Medical Center Los Angeles, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
NCT00025415
- Conditions
- AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
- Locations
-
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
NCT00026351
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
- Locations
-
- Cancer and Blood Institute of the Desert Rancho Mirage, California, United States
- Redding Medical Center Redding, California, United States
- Oncology-Hematology Associates, P.A. Clinton, Maryland, United States
- North Shore Hematology/Oncology Associates, P.C. East Setauket, New York, United States
NCT00003451
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States
NCT00008359
- Conditions
- Adnexal Diseases, Agranulocytosis, Amyloidosis, +141 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00255749
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +64 more
- Locations
-
- Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
NCT00296023
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +64 more
- Locations
-
- Alta Bates Comprehensive Cancer Center Berkeley, California, United States
- UCSF Comprehensive Cancer Center San Francisco, California, United States
Completed
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
NCT00005626
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT00110045
- Conditions
- Adnexal Diseases, Amyloidosis, Ataxia, +137 more
- Locations
-
- CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium
- Centre Hospitalier Universitaire Henri Mondor Créteil, France
- Hopital Edouard Herriot - Lyon Lyon, France
- Hopital Saint-Louis Paris, France